Pathogenesis of myasthenia gravis

Area of Science:

• Immunology
• Neurology
• Pathogenesis of Autoimmune Diseases

Background:

• Myasthenia gravis (MG) is a well-defined autoimmune disorder.
• It is characterized by autoantibodies and T-cell involvement.
• Thymus pathology is observed in approximately 80% of MG cases.

Purpose of the Study:

• To review the pathogenesis of myasthenia gravis.
• To explore the role of the thymus in MG development.
• To differentiate between thymitis-associated and thymoma-associated MG.

Main Methods:

• Review of existing literature on MG pathogenesis over 25 years.
• Analysis of animal models and human studies.
• Examination of autoimmune responses against the acetylcholine receptor (AChR).

Main Results:

• In thymitis-associated MG, intrathymic production of AChR autoantibodies occurs, driven by AChR on myoid cells.
• Genetic factors are crucial in thymitis-associated MG.
• In thymoma-associated MG, thymomas express neurofilaments that mimic AChR, triggering autoimmunity via molecular mimicry; genetic factors are less significant.

Conclusions:

• The thymus, in both inflammatory (thymitis) and neoplastic (thymoma) states, is a critical site for initiating MG pathogenesis.
• The precise initial triggers for MG remain enigmatic across all subtypes.
• Understanding these mechanisms is key to developing targeted therapies for myasthenia gravis.